Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07448753

ACTG2/FLNA Testing Yield in Adult Idiopathic Chronic Intestinal Pseudo-Obstruction (CIPO) With Reduced/Absent Distal Esophageal Contractility

Diagnostic Yield of ACTG2 and FLNA Gene Assessment in Adult Patients With Idiopathic Chronic Intestinal Pseudo-Obstruction and Reduced or Absent Distal Esophageal Contractility

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Marina Coletta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the diagnostic yield of Sanger sequencing for ACTG2 and FLNA genes evaluation on blood or saliva sample in patients with idiopathic CIPO in which high-resolution esophageal manometry (HRM) shows reduced (DCI \<450 mmHg\*s\*cm) or absent distal esophageal contractility.

Conditions

Timeline

Start date
2025-09-17
Primary completion
2026-09-30
Completion
2027-01-30
First posted
2026-03-04
Last updated
2026-03-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07448753. Inclusion in this directory is not an endorsement.